Ep. 533 “Under 60 or Else?” – The Dangerous Myth Limiting Women’s Hormone Therapy
- Cynthia Thurlow, NP
- Dec 25, 2025
- 1 min read
We have another AMA episode today, where I answer some of the most frequently asked podcast listener questions.
In response to a question from Catherine, we unpack the timing hypothesis in this episode, exploring the cardiovascular nuances and clarifying why individualized care truly matters.
IN THIS EPISODE, YOU WILL LEARN:
Cardiovascular and metabolic benefits of starting hormone therapy within about 10 years of menopause onset
What the timing hypothesis really means in clinical practice
Why feeling better does not necessarily imply long-term disease risk has been reduced
How endothelial (blood vessel) health influences the effectiveness of hormone therapy
Why metabolic changes after menopause matter more than most women realize
How their hormone therapy decisions must change as women move further beyond menopause
Risks and benefits of oral versus transdermal hormone delivery
Value of shared patient-clinician decision-making
How lifestyle habits and risk assessment form the foundation for safe, effective, and personalized hormone therapy decisions
“No one should tell you that choosing to use hormone replacement therapy is a crutch.”
– Cynthia Thurlow
Connect with Cynthia Thurlow
Follow on X, Instagram & LinkedIn
Check out Cynthia’s website
Submit your questions to support@cynthiathurlow.com
Transcript: